Nurse Practitioner in Bolton, MS Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Jean Pennington Marks, GNP-BC Nurse Practitioner - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 115 W Madison St, Bolton, MS 39041 Phone: 601-866-7723 Fax: 601-866-7773 |
Amy Monett-shamon Shoulders Thomas, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 115 W Madison St, Bolton, MS 39041 Phone: 601-866-7723 Fax: 601-866-7773 |
News Archive
Sanford Hospital starts clinical trial to study dissolving device in patients with CAD
Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.
Many senior drivers unaware of potential impact on driving performance associated with taking medications
The findings, released today by the AAA Foundation for Traffic Safety, indicate that 95 percent of those age 55 and older have one or more medical conditions, 78 percent take one or more medications, and only 28 percent have an awareness of the risks those medications might have on driving ability.
Study: Malpractice costs $55.6 billion annually, most in defensive medicine
An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.
Human Genome Sciences, Lonza announce commercial supply agreement for BENLYSTA
Human Genome Sciences, Inc. and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE). BENLYSTA is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in 2006.
› Verified 4 days ago